Medicare Enrolled
Dr. Rama Koya, MD
Medical Oncology · Longview, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Koya from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Koya?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Koya
Dr. Rama Koya is a medical oncology specialist in Longview, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Koya performed 57,823 Medicare services across 4,776 unique beneficiaries.
Between the years covered by Open Payments, Dr. Koya received a total of $6,688 from 36 pharmaceutical and/or device companies across 100 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Koya is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 17% volume in TX
$6,688 industry payments
Medicare Practice Summary
Medicare Utilization ↗57,823
Medicare services
Top 17% in TX for medical oncology
4,776
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,043 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
13,581 | $0 | $3 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
11,000 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 10,400 | $43 | $137 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
9,180 | $0 | $5 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
2,339 | $8 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,889 | $8 | $36 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
1,625 | $10 | $64 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
728 | $0 | $1 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
601 | $91 | $368 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
442 | $60 | $250 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
410 | $13 | $60 |
| Iron level test | 393 | $6 | $27 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
393 | $9 | $35 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
333 | $6 | $34 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
322 | $4 | $22 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
268 | $6 | $31 |
| Reticulated platelet measurement A blood test that measures the level of young, newly formed platelets in the body. |
261 | $35 | $143 |
| Anti-nausea injection (Aloxi/palonosetron) | 240 | $1 | $114 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
219 | $9 | $56 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
217 | $14 | $73 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
213 | $15 | $76 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
174 | $97 | $707 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
152 | $2 | $300 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
129 | $51 | $821 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
128 | $8 | $49 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
118 | $16 | $80 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
110 | $11 | $108 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
109 | $168 | $1,067 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
105 | $19 | $99 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
98 | $131 | $496 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
97 | $6 | $431 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
95 | $4 | $25 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
93 | $22 | $157 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
86 | $61 | $247 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
81 | $11 | $96 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
74 | $46 | $313 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
68 | $7 | $29 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
66 | $35 | $686 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
60 | $75 | $560 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 59 | $90 | $657 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
56 | $28 | $247 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
53 | $1 | $7 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
52 | $1,099 | $4,802 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
51 | $21 | $164 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
51 | $49 | $344 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
51 | $71 | $70 |
| Beta-2 microglobulin level test A blood test that measures the level of beta-2 microglobulin, a protein produced by cells in the body. |
46 | $16 | $96 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
37 | $13 | $61 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
37 | $112 | $565 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
37 | $38 | $135 |
| PSA test (prostate cancer screening) | 33 | $18 | $94 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
32 | $5 | $31 |
| Blood urea nitrogen test A blood test that measures the amount of urea nitrogen to assess kidney function. |
32 | $4 | $24 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
31 | $61 | $264 |
| New patient office visit, complex (60-74 min) | 30 | $159 | $709 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
29 | $2 | $19 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 26 | $349 | $1,722 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
26 | $1 | $8 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
24 | $100 | $470 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
24 | $133 | $694 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
23 | $19 | $114 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
22 | $42 | $289 |
| CT scan of neck soft tissue with contrast A computed tomography scan that uses contrast dye to create detailed images of the soft tissues in the neck. |
21 | $51 | $658 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
16 | $2 | $16 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
15 | $133 | $523 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
12 | $25 | $256 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
16.6% high complexity
64.1% medium
19.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,688
Total received (2018-2024)
Avg $955/year across 7 years
Top 42% in TX for medical oncology
36
Companies
100
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,923 (58.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,173 (17.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$959 (14.3%)
Other
Charitable contributions, space rental, and other categories
$633 (9.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,844
2023
$1,113
2022
$2,761
2021
$12
2020
$350
2019
$318
2018
$292
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$3,317
Novartis Pharmaceuticals Corporation
$403
BeiGene USA, Inc.
$375
Janssen Biotech, Inc.
$351
Athenex Pharmaceutical Division, LLC
$350
NOVARTIS PHARMACEUTICALS CORPORATION
$299
COMSORT, Inc
$250
ABBVIE INC.
$156
GlaxoSmithKline, LLC.
$97
E.R. Squibb & Sons, L.L.C.
$97
Amgen Inc.
$95
Daiichi Sankyo Inc.
$86
Myriad Genetic Laboratories, Inc.
$81
Pharmacyclics LLC, An AbbVie Company
$70
Lilly USA, LLC
$66
SOBI, INC
$66
Aveo Pharmaceuticals, Inc.
$65
Incyte Corporation
$53
Merck Sharp & Dohme LLC
$49
Astellas Pharma US Inc
$40
Bayer Healthcare Pharmaceuticals Inc.
$38
Blueprint Medicines Corporation
$35
Seagen Inc.
$32
Regeneron Healthcare Solutions, Inc.
$28
Mirati Therapeutics, Inc.
$24
Stemline Therapeutics Inc.
$22
JAZZ PHARMACEUTICALS INC.
$20
Sun Pharmaceutical Industries Inc.
$19
GENZYME CORPORATION
$18
CTI BioPharma Corp.
$17
PUMA BIOTECHNOLOGY, INC.
$14
Seattle Genetics, Inc.
$12
Acrotech Biopharma LLC
$12
Gilead Sciences, Inc.
$12
PFIZER INC.
$12
Janssen Pharmaceuticals, Inc
$8
Top 3 companies account for 61.2% of total payments
Associated products mentioned in payments ›
ADCETRIS · AYVAKIT · BELEODAQ · DARZALEX · DOPTELET · Doptelet · EPKINLY · Enhertu · Erleada · FOTIVDA · IMBRUVICA · IMFINZI · IMJUDO · JAKAFI · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LUTATHERA · LYNPARZA · MONJUVI · Nubeqa · OJJAARA · OPDIVO · Odomzo · Orserdu · PADCEV · PLUVICTO · PROMACTA · PreciseTumor · SARCLISA · SCEMBLIX · SHINGRIX · Stivarga · TECVAYLI · VERZENIO · VONJO · Vonjo · XALKORI · Xospata · ZEJULA · ZEPZELCA · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (59%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Equivalent to $12 per 100 Medicare services performed
Geographic Context
Medical oncologists within 10 mi
4
Per 100K population
3.2
County median income
$64,809
Nearest hospital
CHRISTUS GOOD SHEPHERD MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Koya is a mixed practice specialist, with above-average Medicare volume (top 17% in TX), with consulting-driven industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Koya experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Koya performed 13,581 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Koya receive payments from pharmaceutical companies?
Yes. Dr. Koya received a total of $6,688 from 36 companies across 100 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Koya's costs compare to other medical oncologists in Longview?
Dr. Koya's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Koya) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Longview
Browse medical oncologists in Longview ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in TX
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in TX
Which TX medical oncologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
BeiGene USA, Inc. Payments to Doctors
See all physicians who received payments from BeiGene USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology